J. Rowley

发表

Allogeneic Cell Therapy Bioprocess Economics and Optimization: Single-Use Cell Expansion Technologies

A. S. Simaria, H. Varadaraju, S. Hassan, 2013, Biotechnology and bioengineering.

Aggregation of Culture Expanded Human Mesenchymal Stem Cells in Microcarrier-based Bioreactor.

T. Ma, A. Tsai, Xuegang Yuan, 2018, Biochemical engineering journal.

Concise Review: Process Development Considerations for Cell Therapy

H. Brandwein, Lior Raviv, S. Oh, 2015, Stem cells translational medicine.

Injection molding of chondrocyte/alginate constructs in the shape of facial implants.

D J Mooney, D. Mooney, C. Vacanti, 2001, Journal of biomedical materials research.

Hydrogels used for cell-based drug delivery.

H. Kong, J. Rowley, Hyun Joon Kong, 2008, Journal of biomedical materials research. Part A.

Alginate hydrogels as synthetic extracellular matrix materials.

D J Mooney, D. Mooney, G. Madlambayan, 1999, Biomaterials.

Controlling Mechanical and Swelling Properties of Alginate Hydrogels Independently by Cross-Linker Type and Cross-Linking Density

Jon A. Rowley, David J. Mooney, D. Mooney, 2000 .

Corporate profile: RoosterBio, Inc.

J. Rowley, T. Olsen, 2018, Regenerative medicine.

Release from alginate enhances the biological activity of vascular endothelial growth factor.

D J Mooney, D. Mooney, B. Isenberg, 1998, Journal of biomaterials science. Polymer edition.

Bioreactor Parameters for Microcarrier-Based Human MSC Expansion under Xeno-Free Conditions in a Vertical-Wheel System

Josephine Lembong, J. Rowley, L. Lock, 2020, Bioengineering.

Strategies for scalable manufacturing and translation of MSC-derived extracellular vesicles.

Kelvin S. Ng, J. Rowley, K. Adlerz, 2020, Stem cell research.

PEG Cross-Linked Alginate Hydrogels with Controlled Mechanical Properties

D. Mooney, J. Rowley, P. Eiselt, 1998 .

Managing particulates in cellular therapy.

M. Mccaman, R. Maziarz, J. Rowley, 2012, Cytotherapy.

Tissue repair cells for the treatment of cardiovascular diseases

E. Burchardt, J. Rowley, M. Peters, 2007 .

Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry.

Christopher A Bravery, Jessica Carmen, Timothy Fong, 2013, Cytotherapy.

Peak MSC—Are We There Yet?

Jon A. Rowley, Timothy R. Olsen, Kelvin S. Ng, 2018, Front. Med..

Meeting Lot-Size Challenges of Manufacturing Adherent Cells for Therapy

Jon A. Rowley, Andrew Campbell, Eytan Abraham, 2012 .

Peak serum: implications of serum supply for cell therapy manufacturing.

Chris Mason, Jon A Rowley, David A Brindley, 2012, Regenerative medicine.

Method for determining oxygen consumption rates of static cultures from microplate measurements of pericellular dissolved oxygen concentration

J. B. Pitner, J. Rowley, Laura E. Dike, 2004, Biotechnology and bioengineering.

Scalable Passaging of Adherent Human Pluripotent Stem Cells

J. Rowley, T. Fellner, Patrick Walsh, 2014, PloS one.

Effect of substrate mechanics on chondrocyte adhesion to modified alginate surfaces.

L. Bonassar, D. Mooney, J. Rowley, 2004, Archives of biochemistry and biophysics.

Downstream Technology Landscape for Large-Scale Therapeutic Cell Processing

Hemanthram Varadaraju, Jon A. Rowley, Jacob Pattasseril, 2013 .

Engineering growing tissues

Eben Alsberg, David J Mooney, K. W. Anderson, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Bioprocess decision support tool for scalable manufacture of extracellular vesicles

Brock Reeve, Jeffrey M Karp, Alison R Carter, 2018, Biotechnology and bioengineering.

Alginate type and RGD density control myoblast phenotype.

David J Mooney, Jon A Rowley, D. Mooney, 2002, Journal of biomedical materials research.

Soft-Tissue Augmentation with Injectable Alginate and Syngeneic Fibroblasts

J. Vacanti, J. Upton, J. Rowley, 2000, Plastic and reconstructive surgery.

Developing assays to address identity, potency, purity and safety: cell characterization in cell therapy process development.

Scott R Burger, Jon A Rowley, M. Mccaman, 2012, Regenerative medicine.

Biomaterials to Spatially Regulate Cell Fate

Jon A. Rowley, David J. Mooney, Daniel Goldman, 2002 .

Adult Stem Cell Therapies for Tissue Regeneration: Ex Vivo Expansion in an Automated System

Jon A. Rowley, Ronnda L. Bartel, J. Dennis, 2008 .

Method for determining oxygen consumption rates of static cultures from microplate measurements of pericellular dissolved oxygen concentration

J. B. Pitner, J. Rowley, M. Timmins, 2004, Biotechnology and bioengineering.

A hydrogel material for plastic and reconstructive applications injected into the subcutaneous space of a sheep.

K. Burg, D. Mooney, J. Rowley, 2002, Tissue engineering.

Cryopreserved hMSCs maintain comparable in vitro functional activity compared to fresh hMSCs

J. Rowley, P. Baraniak, L. Lock, 2015 .

Managing particulates in cellular therapy.

M. Mccaman, R. Maziarz, J. Rowley, 2012, Cytotherapy.

Downstream Technology Landscape for Large-Scale Therapeutic Cell Processing

H. Varadaraju, J. Rowley, L. Lock, 2013 .